his prospective multicenter Italian study examined clinical outcomes of hypertriglyceridemia-associated acute pancreatitis (HTG-AP) compared to other etiologies 1. The study included 86 patients across 14 Italian centers, with 38 patients (44.2%) diagnosed with HTG-AP . Key Findings: Local Complications: HTG-AP patients showed significantly higher rates of pancreatic necrosis (36.8% vs. 14.6%) and pseudocyst/walled-off necrosis (15.8% vs. 2.1%). Overall Severity: Despite increased local complications, HTG-AP patients had similar overall severity, ICU admission rates, length of stay, and mortality compared to other AP etiologies. Recurrence: AP recurrence occurred in approximately 9% of patients during one-year follow-up, with similar rates between groups. Conclusions: The study suggests HTG-AP represents a distinct phenotype with preferential pancreatic injury rather than systemic inflammatory response. Early triglyceride measurement is essential for all AP patients regardless of presumed etiology.
Clinical outcomes of hypertriglyceridemia-associated acute pancreatitis: a prospective multicenter Italian cohort
De Marchi, Giulia;de Pretis, Nicolò;Agnolon, Clara;Stegagnini, Marta;Carrara, Silvia;Frulloni, Luca
2026-01-01
Abstract
his prospective multicenter Italian study examined clinical outcomes of hypertriglyceridemia-associated acute pancreatitis (HTG-AP) compared to other etiologies 1. The study included 86 patients across 14 Italian centers, with 38 patients (44.2%) diagnosed with HTG-AP . Key Findings: Local Complications: HTG-AP patients showed significantly higher rates of pancreatic necrosis (36.8% vs. 14.6%) and pseudocyst/walled-off necrosis (15.8% vs. 2.1%). Overall Severity: Despite increased local complications, HTG-AP patients had similar overall severity, ICU admission rates, length of stay, and mortality compared to other AP etiologies. Recurrence: AP recurrence occurred in approximately 9% of patients during one-year follow-up, with similar rates between groups. Conclusions: The study suggests HTG-AP represents a distinct phenotype with preferential pancreatic injury rather than systemic inflammatory response. Early triglyceride measurement is essential for all AP patients regardless of presumed etiology.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



